Lucid Diagnostics (LUCD) Income towards Parent Company (2020 - 2026)
Lucid Diagnostics' (LUCD) quarterly Income towards Parent Company came in at -$13.9 million in Q1 2026, up 48.31% YoY from -$9.4 million in Q1 2025, and up 14.49% on a QoQ basis from -$16.3 million in Q4 2025.
Lucid Diagnostics (LUCD) Income towards Parent Company (2020 - 2026) Analysis & Trends
Lucid Diagnostics (LUCD) has 7 years of Income towards Parent Company data on file, last reported at -$13.9 million in Q1 2026.
- Quarterly Income towards Parent Company rose 48.31% year-over-year to -$13.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$45.0 million (up 27.2% YoY) and the FY2025 annual result came in at -$58.0 million, down 27.41% from the prior year.
- Income towards Parent Company climbed to -$13.9 million in Q1 2026, from -$16.3 million in the prior quarter.
- In the past five years, Income towards Parent Company ranged from a high of -$4.4 million in Q2 2025 to a low of -$26.9 million in Q1 2025.
- A 5-year average of -$13.3 million and a median of -$12.4 million in 2024 frame the typical range for Income towards Parent Company.
- Annual changes were most pronounced in 2022 — Income towards Parent Company slumped 235.89% — and 2025, when it jumped 59.66%.
- Tracing LUCD's Income towards Parent Company over 5 years: stood at -$14.9 million in 2022, then rose by 27.45% to -$10.8 million in 2023, then decreased by 6.57% to -$11.5 million in 2024, then plunged by 40.94% to -$16.3 million in 2025, then rose by 14.49% to -$13.9 million in 2026.
- The last three Income towards Parent Company figures came in at -$13.9 million (Q1 2026), -$16.3 million (Q4 2025), and -$10.4 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.63 Bn | 194.02 Bn | 7.27 Bn |
| 2 | Stryker | 127.42 Bn | 123.95 Bn | 4.50 Bn |
| 3 | Medtronic | 118.97 Bn | 109.75 Bn | 6.41 Bn |
| 4 | Boston Scientific | 73.39 Bn | 72.85 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.97 Bn | 47.72 Bn | 1.35 Bn |
| 6 | Dexcom | 34.32 Bn | 32.37 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.65 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.35 Bn | 23.03 Bn | 4.55 Bn |
| 9 | Steris | 23.04 Bn | 22.56 Bn | 684.20 Mn |
| 10 | Lucid Diagnostics | 176.73 Mn | 143.33 Mn | 55,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -11.69 Mn |
| Mar 31, 2026 | -13.91 Mn |
| Dec 31, 2025 | -16.27 Mn |
| Sep 30, 2025 | -10.40 Mn |
| Jun 30, 2025 | -4.44 Mn |
| Mar 31, 2025 | -26.91 Mn |
| Dec 31, 2024 | -11.54 Mn |
| Sep 30, 2024 | -12.37 Mn |
| Jun 30, 2024 | -11.01 Mn |
| Mar 31, 2024 | -10.61 Mn |
| Dec 31, 2023 | -10.83 Mn |
| Sep 30, 2023 | -14.21 Mn |
| Jun 30, 2023 | -11.38 Mn |
| Mar 31, 2023 | -16.25 Mn |
| Dec 31, 2022 | -14.93 Mn |
| Sep 30, 2022 | -14.35 Mn |
| Jun 30, 2022 | -14.62 Mn |
| Mar 31, 2022 | -12.27 Mn |
| Dec 31, 2021 | -11.31 Mn |
| Sep 30, 2021 | -6.96 Mn |